VIDEO from Medialink and Your Baby Can Read: Early Literacy in Children ... Proven Path ...(ossible early learning skills are the gr...),Health
Navigation Links
VIDEO from Medialink and Your Baby Can Read: Early Literacy in Children ... Proven Path to Success
Date:12/12/2008
ossible, early learning skills are the greatest gift a parent can provide.
Dr. Titzer taught his own children to read as babies with an award-winning Early Language Development system he developed called "Your Baby Can Read!" For more information on early learning skills and "Your Baby Can Read!" visit http://www.yourbabycanread.com.
12LA08-0094
'/>"/>
| SOURCE Medialink and Your Baby Can Read Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Video: Nutrition Comes to NASCAR
2. Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Video: Circulatory Care of New Jersey
5. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
6. VIDEO from Medialink and General Motors: On and Off the Track
7. TriWest and Montana VA Launch PTSD Video Conference to Reach Rural Health Care Providers
8. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
9. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
10. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
11. VIDEO from Medialink and General Mills: Digestive Health
Post Your Comments:
Breaking Medicine News(10 mins):Health News:New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe 2Health News:New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe 3Health News:New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe 4Health News:New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe 5Health News:New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe 6Health News:New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe 7Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 2Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 3Health News:2010 Will Be a Great Year for a Change! Start a New Career Now! 2Health News:Procter & Gamble Announces Appointment of Director 2Health News:Scripps Research scientists reveal key structure from ebola virus 2
[0] New Health Report Exposes Imminent Risk of a Stroke Crisis in Europe[0] Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections[1] 2010 Will Be a Great Year for a Change! Start a New Career Now![0] Procter & Gamble Announces Appointment of Director[1] Scripps Research scientists reveal key structure from ebola virus
Other Medicine News:Health News:Fatty Fish May Cut Heart Failure Risk in Men 2Health News:Wainwright Bank Provides $10 Million in New Markets Tax Credits and $7.4 Million in Financing to Hope House 2Health News:NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR 2Health News:NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR 3Health News:NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR 4Health News:Haemonetics Sets Date for Investor/Analyst Meeting 2Health News:Family Healthcare Network Selects InteGreat EHR for Deployment of Browser-Based EHR 2Health News:Family Healthcare Network Selects InteGreat EHR for Deployment of Browser-Based EHR 3
Latina Actress Constance Marie Opens Up About Her Struggle to Conceive and Shares Her Knowledge on Organic Baby Care.Fatty Fish May Cut Heart Failure Risk in MenWainwright Bank Provides $10 Million in New Markets Tax Credits and $7.4 Million in Financing to Hope HouseNKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACRHaemonetics Sets Date for Investor/Analyst MeetingFamily Healthcare Network Selects InteGreat EHR for Deployment of Browser-Based EHR
Breaking Medicine Technology:Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 1Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 2Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 1Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 2Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 3Calling All Runners 3A Join the Fight Against Cancer 50493 1Calling All Runners 3A Join the Fight Against Cancer 50493 2
[0] Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009[0] Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia[0] Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
Other Medicine Technology:Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |